Walking Fish Therapeutics, Inc.

๐Ÿ“ South San Francisco, United States๐Ÿ‘ฅ 16 employees๐Ÿ’ฐ Last funded Aug 2021
Walking Fish has created a broad B cell platform for oncology, regenerative medicine, autoimmune disease, and recombinant antibody production. As a leader in B cell engineering, Walking Fish has made critical advances in engineering technologies and has a deep understanding about B cell biology. The WFT team includes experienced researchers excited about our new approach to the treatment of severe diseases.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
โ€”
Founded
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Walking Fish Therapeutics, Inc.?
Walking Fish Therapeutics, Inc. has 1 investors on record on gritt.io.
When did Walking Fish Therapeutics, Inc. last raise funding?
The most recent investment in Walking Fish Therapeutics, Inc. recorded on gritt.io was in August 2021.
What industry is Walking Fish Therapeutics, Inc. in?
Walking Fish Therapeutics, Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Walking Fish Therapeutics, Inc. based?
Walking Fish Therapeutics, Inc. is headquartered in South San Francisco, United States.